AR013132A1 - Un compuesto derivado de tetrahidroimidazo[2,1-a]isoquinolina, su uso y una formulacion farmaceutica que lo comprende. - Google Patents
Un compuesto derivado de tetrahidroimidazo[2,1-a]isoquinolina, su uso y una formulacion farmaceutica que lo comprende.Info
- Publication number
- AR013132A1 AR013132A1 ARP980103061A ARP980103061A AR013132A1 AR 013132 A1 AR013132 A1 AR 013132A1 AR P980103061 A ARP980103061 A AR P980103061A AR P980103061 A ARP980103061 A AR P980103061A AR 013132 A1 AR013132 A1 AR 013132A1
- Authority
- AR
- Argentina
- Prior art keywords
- tetrahydroimidazo
- pharmaceutical formulation
- isoquinoline
- compound derived
- 6alkynyl
- Prior art date
Links
- FRWLUUVHISZFNT-UHFFFAOYSA-N 1,2,3,5-tetrahydroimidazo[2,1-a]isoquinoline Chemical compound C1C=C2C=CC=CC2=C2N1CCN2 FRWLUUVHISZFNT-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000013160 medical therapy Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201950 | 1997-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR013132A1 true AR013132A1 (es) | 2000-12-13 |
Family
ID=8228485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980103061A AR013132A1 (es) | 1997-06-26 | 1998-06-25 | Un compuesto derivado de tetrahidroimidazo[2,1-a]isoquinolina, su uso y una formulacion farmaceutica que lo comprende. |
Country Status (27)
Country | Link |
---|---|
US (1) | US5994366A (pt) |
EP (1) | EP0887349B1 (pt) |
JP (1) | JP4339939B2 (pt) |
KR (1) | KR100540317B1 (pt) |
CN (1) | CN1139589C (pt) |
AR (1) | AR013132A1 (pt) |
AT (1) | ATE209649T1 (pt) |
AU (1) | AU737924B2 (pt) |
BR (1) | BR9802286A (pt) |
CA (1) | CA2241469C (pt) |
CZ (1) | CZ293265B6 (pt) |
DE (1) | DE69802624T2 (pt) |
DK (1) | DK0887349T3 (pt) |
ES (1) | ES2169471T3 (pt) |
HK (1) | HK1018059A1 (pt) |
HU (1) | HUP9801451A3 (pt) |
ID (1) | ID20494A (pt) |
IL (1) | IL124914A (pt) |
NO (1) | NO311028B1 (pt) |
NZ (1) | NZ330722A (pt) |
PL (1) | PL190281B1 (pt) |
PT (1) | PT887349E (pt) |
RU (1) | RU2204560C2 (pt) |
SG (1) | SG66484A1 (pt) |
TR (1) | TR199801175A1 (pt) |
TW (1) | TW513411B (pt) |
ZA (1) | ZA985559B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20060653A1 (es) * | 2004-08-31 | 2006-09-27 | Glaxo Group Ltd | Derivados triciclicos condensados como moduladores del receptor 5-ht1 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3624093A (en) * | 1970-03-10 | 1971-11-30 | American Home Prod | 5,6-disubstituted-2,3,5,6-tetrahydroimidazo-{8 2,1-{60 {9 isoquinolin-6-ols |
US4100165A (en) * | 1975-06-17 | 1978-07-11 | Sandoz, Inc. | Imidazo [2,1-a]isoquinolines |
-
1998
- 1998-06-15 IL IL12491498A patent/IL124914A/xx not_active IP Right Cessation
- 1998-06-16 TW TW087109737A patent/TW513411B/zh not_active IP Right Cessation
- 1998-06-18 NZ NZ330722A patent/NZ330722A/xx unknown
- 1998-06-22 SG SG1998001482A patent/SG66484A1/en unknown
- 1998-06-22 TR TR1998/01175A patent/TR199801175A1/xx unknown
- 1998-06-23 CA CA002241469A patent/CA2241469C/en not_active Expired - Fee Related
- 1998-06-23 ES ES98202076T patent/ES2169471T3/es not_active Expired - Lifetime
- 1998-06-23 PT PT98202076T patent/PT887349E/pt unknown
- 1998-06-23 EP EP98202076A patent/EP0887349B1/en not_active Expired - Lifetime
- 1998-06-23 AT AT98202076T patent/ATE209649T1/de not_active IP Right Cessation
- 1998-06-23 DK DK98202076T patent/DK0887349T3/da active
- 1998-06-23 DE DE69802624T patent/DE69802624T2/de not_active Expired - Fee Related
- 1998-06-25 AU AU73196/98A patent/AU737924B2/en not_active Ceased
- 1998-06-25 NO NO19982952A patent/NO311028B1/no unknown
- 1998-06-25 CN CNB981031846A patent/CN1139589C/zh not_active Expired - Fee Related
- 1998-06-25 KR KR1019980024044A patent/KR100540317B1/ko not_active IP Right Cessation
- 1998-06-25 HU HU9801451A patent/HUP9801451A3/hu unknown
- 1998-06-25 ZA ZA985559A patent/ZA985559B/xx unknown
- 1998-06-25 US US09/104,563 patent/US5994366A/en not_active Expired - Lifetime
- 1998-06-25 ID IDP980913A patent/ID20494A/id unknown
- 1998-06-25 BR BR9802286-5A patent/BR9802286A/pt not_active Application Discontinuation
- 1998-06-25 AR ARP980103061A patent/AR013132A1/es active IP Right Grant
- 1998-06-25 RU RU98112179/04A patent/RU2204560C2/ru not_active IP Right Cessation
- 1998-06-26 CZ CZ19982048A patent/CZ293265B6/cs not_active IP Right Cessation
- 1998-06-26 PL PL98327053A patent/PL190281B1/pl not_active IP Right Cessation
- 1998-06-26 JP JP18031198A patent/JP4339939B2/ja not_active Expired - Fee Related
-
1999
- 1999-07-06 HK HK99102885A patent/HK1018059A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3365772D1 (en) | 1,4-dihydropyridines, process for their preparation and their application as pharmaceutical preparations | |
KR870700620A (ko) | 신규 약리학적 화합물 | |
BR0015605A (pt) | Composição e uso | |
HUP0102793A2 (hu) | Agydaganat kezelésére szolgáló kinazolinok és ezeket tartalmazó gyógyszerkészítmények | |
SE8602723L (sv) | Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem | |
YU47116B (sh) | Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata | |
ATE233754T1 (de) | Diphenyl-piperidin derivate | |
IT1255802B (it) | Derivati imidazolici ad attivita' a ii antagonista | |
DE68902301D1 (de) | Diarylverbindungen als antiatherosklerotische mittel. | |
ATE92036T1 (de) | Kardiovaskulaer aktive verbindungen. | |
AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
AR013132A1 (es) | Un compuesto derivado de tetrahidroimidazo[2,1-a]isoquinolina, su uso y una formulacion farmaceutica que lo comprende. | |
DK624989D0 (da) | Hidtil ukendte forbindelser | |
SE8302751L (sv) | 2(1h)-pyridinonderivat, deras framstellning och farmaceutiska beredningar som innehaller dem | |
PT861250E (pt) | Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase | |
GEP20032975B (en) | Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition | |
IL84096A (en) | Therapeutic compositions for the treatment of peptic ulcer disease comprising a 1-(oxoalkyl)-3,7-dialkylxanthine | |
ES2095431T3 (es) | N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
DK0466662T3 (da) | 6,7-Disubstituerede-2-aminotetraliner, der er aktive som immunmodulatorer, samt farmaceutiske præparater indeholdende sådanne forbindelser | |
AR031104A1 (es) | Composicion farmaceutica que comprende un carboxialquileter y un agente antihipertensivo, primera composicion para su uso con una segunda composicion que comprenden un agente antihipertensivo y un carboxialquileter respectivamente, equipo que comprende un carboxialquileter y un agente antihipertensi | |
DK165967C (da) | Anvendelse af en 2-oxo-imidazolidinforbindelse til fremstilling af et farmaceutisk praeparat | |
DE60029946D1 (de) | Arzneimittel gegen glomerulosclerose | |
TH40676A (th) | อนุพันธ์เททราไฮโดรอิมิดาโซ [2,1-เอ] ไอโซควิโนลิน | |
RU98112179A (ru) | Производные тетрагидроимидазо [2,1-a]изохинолина | |
ATE92037T1 (de) | Kardiovaskulaer aktive verbindungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |